NCR2 and sarcoma: Expression of other checkpoint molecules such as T-cell immunoglobulin and mucin domain-3 (TIM-3) ligands and NKp44-inhibiting proliferating cell nuclear antigen (PCNA) was also reported in sarcomas [45,139].